Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01770236 · ClinicalTrials.gov registry record · Phase 4
Pain Control After Minimally Invasive Coronary Artery Bypass Grafting
A Phase 4 study, sponsored by Gundersen Lutheran Medical Foundation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT01770236 is a Phase 4 study that was terminated before completion, run by Gundersen Lutheran Medical Foundation. The registered enrollment target is 41 participants.
The verdict
NCT01770236, a Phase 4 study, was terminated before completion, sponsored by Gundersen Lutheran Medical Foundation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to compare postoperative pain control after minimally invasive coronary artery bypass grafting for patients who receive an intercostal block (an anesthetic medicine injected in an area under the ribs) in the operating room and IV acetaminophen (Tylenol) to those who receive an intercostal block and On-Q pain pump catheter (a balloon pump attached to 2 small tubes near your procedure site that automatically delivers pain medicine).
Interventions
- DRUG IV acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01770236
The ClinicalTrials.gov registry entry for NCT01770236 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gundersen Lutheran Medical Foundation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IV acetaminophen is the first listed.
NCT01770236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01770236 about?
NCT01770236 is a clinical study titled "Pain Control After Minimally Invasive Coronary Artery Bypass Grafting". The purpose of this study is to compare postoperative pain control after minimally invasive coronary artery bypass grafting for patients who receive an intercostal block (an anesthetic medicine injected in an area under the ribs) in the operating room and IV acetaminophen (Tylenol) to those who rece...
What is the current status of trial NCT01770236?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2013-01. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01770236?
The interventions under investigation include: IV acetaminophen (DRUG).
Who is sponsoring clinical trial NCT01770236?
This trial is sponsored by Gundersen Lutheran Medical Foundation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.